Zhong et al. [37] found a compensatory increase in TDO due to a deficiency of the initiating and rate-limiting enzyme of the TRP-degrading Kyn pathway, indoleamine-2,3-dioxygenase 1 (IDO1), and alleviated CCl4-induced hepatic fibrosis. Here, TDO2 is linked to Hepatic fibrosis.